Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage dna hdac'

Search results for: 'research area dna damage dna hdac'

Items 41-50 of 70

Page
per page
  1. Penciclovir
    B1809 Penciclovir
    Target: HSV
    Summary: HSV-1 DNA synthesis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.95 mg/mL
  2. Mechlorethamine HCl
    B1785 Mechlorethamine HCl
    Summary: DNA synthesis inhibitor
  3. Rocilinostat (ACY-1215)
    A4083 Rocilinostat (ACY-1215)
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Selective HDAC6 inhibitor
      ≥21.675 mg/mL
  4. AR-42 (OSU-HDAC42)
    A4104 AR-42 (OSU-HDAC42)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor,novel and potent
      insoluble in EtOH; insoluble in H2O; ≥15.62 mg/mL
  5. Apicidin
    A8176 Apicidin
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Potent HDAC inhibitor
      soluble in DMSO or ethanol
  6. RG2833
    A3761 RG2833
    Target: HDAC
    Summary: Brain-penetrant HDAC inhibitor
      insoluble in H2O; ≥16.95 mg/mL
  7. AZD7762
    A5919 AZD7762
    Target: Chk
    Summary: Checkpoint kinase inhibitor,ATP competitive
      insoluble in H2O; insoluble in EtOH; ≥18.1 mg/mL
  8. MK-8776 (SCH-900776)
    A8477 MK-8776 (SCH-900776)
    Target: Chk
    Summary: Chk1 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥18.8 mg/mL
  9. EX 527 (SEN0014196)
    A4181 EX 527 (SEN0014196)
     1 Citation
    Target: Sirtuin
    Summary: SIRT1 inhibitor
      insoluble in H2O; ≥12.43 mg/mL
  10. AZD8055
    A8214 AZD8055
     2 Citation
    Target: mTOR
    Summary: MTOR inhibitor
      ≥23.3 mg/mL

Items 41-50 of 70

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 67item
  2. Natural Products 1 item
  3. Peptides 1 item
  4. Peptides & Proteins 1 item
Reversibility
  1. Reversible 4item
Target
  1. Histone Deacetylases (HDACs) 23item
  2. Akt 1 item
  3. PI3K 5item
  4. mTOR 3item
  5. AP-1 1 item
  6. Chk 2item
  7. Thymidylate Synthase 1 item
  8. Trk Receptors 1 item
  9. STAT 3item
  10. JAK 1 item
  11. DNA-PK 5item
  12. Topoisomerases 5item
  13. DNA Methyltransferases 3item
  14. Ubiquitin-specific proteases 1 item
  15. Fatty-acid-binding proteins (FABPs) 1 item
  16. ATM/ATR 2item
  17. BLM 1 item
  18. HSV 1 item
  19. Synthases/Synthetases 2item
  20. MAGL 1 item
  21. RNA Polymerases 1 item
  22. CMV 1 item
  23. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  24. Cytidine deaminases 1 item
  25. HDAC 1 item
  26. ATM 1 item
  27. Sirtuin 1 item
Reported Experiments
  1. Animal Experiments 63item
  2. Cell Experiments 41item
Related Disease
  1. Acute Myelogenous Leukemia 3item
  2. Acute Myeloid Leukemia 1 item
  3. Acute Renal Failure 1 item
  4. Bladder Cancer 2item
  5. Bladder Carcinoma 1 item
  6. Bladder Diseases 1 item
  7. Breast Cancer 18item
  8. Cancer 55item
  9. Cervical Cancer 2item
  10. Chronic Lymphocytic Leukemia 1 item
  11. Colon Cancer 12item
  12. Colorectal Cancer 6item
  13. Dyskinesia 1 item
  14. Friedreich's Ataxia 1 item
  15. Glioblastoma 3item
  16. Glioma 2item
  17. Hepatic Cancer 1 item
  18. Hepatocellular Carcinoma 3item
  19. HIV Infections 2item
  20. Inflammatory Diseases 1 item
  21. Leukemia 4item
  22. Lung Cancer 5item
  23. Lymphoma 5item
  24. Melanoma 5item
  25. Multiple Myeloma 4item
  26. Myeloma 3item
  27. Neuroblastoma 2item
  28. Neuronal Protection 1 item
  29. Non-small Cell Lung Cancer 3item
  30. Non-small Cell Lung Carcinoma 1 item
  31. Ovarian Cancer 9item
  32. Pancreatic Cancer 3item
  33. Prostate Cancer 12item
  34. Renal Cancer 1 item
  35. Renal Cell Carcinoma 1 item
  36. Sarcoma 1 item
  37. Squamous Cell Carcinoma 1 item
  38. Testicular Cancer 2item
  39. Type 2 Diabetes 1 item